Case Study

How Unified Platform Approaches Deliver Up To 13x ROI

Source: Medable
GettyImages-1447084050 data

More than a decade ago, sponsors began deploying virtual and remote solutions to support clinical trial execution. The COVID-19 pandemic, however, catalyzed rapid and extensive adoption of these solutions to reduce the risk of transmitting infection, minimize delays and disruptions, accelerate the collection of clinical research data, facilitate participant access to clinical studies, and lower participation burden.

Commonly referred to as decentralized clinical trials (DCTs), sponsors and contract research organizations (CROs) are now looking for insights into optimizing the value of DCT deployments. This Tufts CSDD Impact Report presents the results of an initial Tufts CSDD study quantifying the net financial return on DCT investment. Value was measured by changes in expected net present value (eNPV). The study looked at three factors for which data were available that can impact eNPV.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader